WS #10426
AbbVie acquires Apogee Therapeutics for $10.9B, gaining pipeline assets in atopic dermatitis and asthma.
AbbVie Acquires Apogee Therapeutics
AbbVie acquires Apogee Therapeutics for $10.9B, gaining pipeline assets in atopic dermatitis and asthma.